| Product NDC: | 0781-3178 |
| Proprietary Name: | Ceftazidime |
| Non Proprietary Name: | Ceftazidime |
| Active Ingredient(s): | 2 g/1 & nbsp; Ceftazidime |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0781-3178 |
| Labeler Name: | Sandoz Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA062640 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20080515 |
| Package NDC: | 0781-3178-95 |
| Package Description: | 10 VIAL, SINGLE-DOSE in 1 TRAY (0781-3178-95) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (0781-3178-91) |
| NDC Code | 0781-3178-95 |
| Proprietary Name | Ceftazidime |
| Package Description | 10 VIAL, SINGLE-DOSE in 1 TRAY (0781-3178-95) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (0781-3178-91) |
| Product NDC | 0781-3178 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Ceftazidime |
| Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20080515 |
| Marketing Category Name | ANDA |
| Labeler Name | Sandoz Inc |
| Substance Name | CEFTAZIDIME |
| Strength Number | 2 |
| Strength Unit | g/1 |
| Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |